Cancer immunotherapy: are the results discouraging? Can they be improved?

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

Vaccine·2001

Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines.

Biochimica et biophysica acta·2001

Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects.

Biochimica et biophysica acta·2001

Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long-circulating liposomes.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2000

Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies.

Cancer immunology, immunotherapy : CII·1999

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.

Vaccine·1999

Cancer immunotherapy with oncolytic myxoma virus.

Advances in cancer research·2026

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Advances in cancer research·2026

Advancing clinical translation of oncolytic adenoviruses.

Advances in cancer research·2026

Operation oncolysis: Reoviruses in the theater of cancer war.

Advances in cancer research·2026

AAV vectors for cancer gene therapy.

Advances in cancer research·2026

Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer.

Advances in cancer research·2026

Targeted Delivery of Carvacrol via TPGS-Tf-Polydopamine Nanoconjugate Scaffold on TNBC Tumor Xenograft for Understanding In Vivo Tumor Dynamics and 3D Cancer Spheroid Model, Mimicking a Tumor Environment.

Molecular pharmaceutics·2026

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Molecular pharmaceutics·2026

Low-Density Lipoprotein-Mimetic Nanoparticles Codelivering Self-Activated Cabazitaxel Prodrug and Verteporfin for Tumor Chemophotodynamic Therapy and Immune Activation.

Molecular pharmaceutics·2026

Correlation Between the Extent of Lateral Neck Lymph Node Dissection and Postoperative Parathyroid Function in Papillary Thyroid Carcinoma.

Journal of investigative surgery : the official journal of the Academy of Surgical Research·2026

The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.

Radiology and oncology·2026

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a single-institution experience.

Radiology and oncology·2026

Related Experiment Videos

Cancer immunotherapy: are the results discouraging? Can they be improved?

Related Concept Videos

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines.

Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects.

Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long-circulating liposomes.

Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies.

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.

Cancer immunotherapy with oncolytic myxoma virus.

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Advancing clinical translation of oncolytic adenoviruses.

Operation oncolysis: Reoviruses in the theater of cancer war.

AAV vectors for cancer gene therapy.

Vesicular stomatitis virus (VSV) as an oncolytic therapeutic agent for cancer.

Targeted Delivery of Carvacrol via TPGS-Tf-Polydopamine Nanoconjugate Scaffold on TNBC Tumor Xenograft for Understanding In Vivo Tumor Dynamics and 3D Cancer Spheroid Model, Mimicking a Tumor Environment.

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Low-Density Lipoprotein-Mimetic Nanoparticles Codelivering Self-Activated Cabazitaxel Prodrug and Verteporfin for Tumor Chemophotodynamic Therapy and Immune Activation.

Correlation Between the Extent of Lateral Neck Lymph Node Dissection and Postoperative Parathyroid Function in Papillary Thyroid Carcinoma.

The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a single-institution experience.

Related Experiment Videos

Cancer immunotherapy: are the results discouraging? Can they be improved?

Related Concept Videos

Related Articles